Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine

Open Access Article

<< Previous

Contents Vol 7(3)

doi:10.1071/SH10075

Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine

Julia M. L. Brotherton ^A ^B ^I, Christopher K. Fairley ^C ^D, Suzanne M. Garland ^E ^F ^G ^H, Dorota Gertig ^A, Marion Saville ^A

^A Victorian Cytology Service, PO Box 310, East Melbourne, Vic. 8002, Australia.
^B National Centre for Immunisation Research and Surveillance, The Children’s Hospital at Westmead, Discipline of Paediatrics and Child Health, School of Public Health, University of Sydney, Sydney, NSW 2006, Australia.
^C Melbourne Sexual Health Centre, 580 Swanston Street, Carlton, Vic. 3053, Australia.
^D School of Population Health, University of Melbourne, Carlton, Vic. 3053, Australia.
^E Clinical Microbiology and Infectious Diseases, Royal Women’s Hospital, Melbourne, Vic. 3052, Australia.
^F Department of Clinical Microbiology, Royal Children’s Hospital, Melbourne, Vic. 3052, Australia.
^G Faculty of Medicine, Dentistry and Health, Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Vic. 3053, Australia.
^H Murdoch Children’s Research Institute, University of Melbourne, Melbourne, Vic. 3052, Australia.
^I Corresponding author. Email: jbrother@vcs.org.au





	Full Text



	PDF (64 KB)



	Export Citation

Print